A roadmap for clinical trials in MASH-related compensated cirrhosis-Reference-Cited by-同舟云学术

A roadmap for clinical trials in MASH-related compensated cirrhosis

Published:2024-07-17 Issue: Volume: Page:
ISSN:1759-5045
Container-title:Nature Reviews Gastroenterology & Hepatology
language:en
Short-container-title:Nat Rev Gastroenterol Hepatol

Author:

Pericàs Juan M.^ORCID,Anstee Quentin M.^ORCID,Augustin Salvador,Bataller Ramón^ORCID,Berzigotti Annalisa^ORCID,Ciudin Andreea,Francque Sven^ORCID,Abraldes Juan G.,Hernández-Gea Virginia,Pons Mònica,Reiberger Thomas^ORCID,Rowe Ian A.^ORCID,Rydqvist Peter,Schabel Elmer,Tacke Frank^ORCID,Tsochatzis Emmanuel A.^ORCID,Genescà Joan^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41575-024-00955-8.pdf

Reference175 articles.

1. Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542–1556 (2023).

2. Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11–20 (2018).

3. Brown, G. T. & Kleiner, D. E. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 65, 1080–1086 (2016).

4. Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O. & Heikenwalder, M. From NASH to HCC: current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 16, 411–428 (2019).

5. Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123–133 (2018).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis;Nature Reviews Gastroenterology & Hepatology;2024-08-05